Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Home
Service Platform
- Small Molecule CDMO Services
  显示更多
- Established Services
  - Capabilities
  - Product Series
  显示更多
- Registration, Filing, and Regulatory Services
  显示更多
Platform
- Small Molecule Drug Platform
  显示更多
- Drug Product (DP) Platforms
  显示更多
- Peptide Platform
  显示更多
- Research Team
  - Scientist Advisory Team
  - Core Research Team
  显示更多
Business Presence
- R&D Centers
- Production Bases
Investor Relations
About
Join
Contact

中文

Investor Relations

Home page

Create maximum return for investors

Stock Info

Jiuzhou Pharma

Stock Code: 603456.SH

Periodic Reports

Performance Briefing

Jiuzhou Pharma Full-Year 2022 and Q1 2023 Performance Briefing

View Details

Jiuzhou Pharma Q3 2022 Performance Briefing

View Details

Jiuzhou Pharma Mid-Year 2022 Performance Briefing

View Details

Jiuzhou Pharma 2021 Annual Performance Briefing

View Details

Investor Contacts

Investment and Securities Department, Jiuzhou Pharma, No. 99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang

Tel:

86-576-88706789

Fax:

86-576-88706788

Email:

603456@jiuzhoupharma.com

Periodic announcements Performance Statement Meeting

Investor Contact

Jiuzhou Pharmaceutical Investment Securities Department, 99 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province

Telephone:

0576-88706789

Fax:

0576-88706780

Mailbox:

603456@jiuzhoupharma.com

Jiuzhou Pharma Full-Year 2022 and Q1 2023 Performance Briefing

Jiuzhou Pharma Q3 2022 Performance Briefing

Jiuzhou Pharma Mid-Year 2022 Performance Briefing

Jiuzhou Pharma 2021 Annual Performance Briefing

Business Collaboration

Innovative Drug CDMO Services

Tel: 86-576-85588039

Email: bd.cdmo@jiuzhoupharma.com

Established Services

Tel: 86-576-88881561

Email: sale@jiuzhoupharma.com

Human Resources

Join Us

Tel: 86-576-88827582

Email: hr@jiuzhoupharma.com

SEO

Business License